CollabRx applied collaborative research to slash the time, cost, and risk of therapy development for neglected diseases. The CollabRx model was comprised of virtual biotechs: networks of scientists, clinicians, and CROs. They aimed to use best practices from Big Pharma, industrial engineering, and academic research, facilitated by Web-based collaboration and ecommerce.

The company was acquired by Tegal in August 2012. Tegal took on CollabRx’s name soon after the acquisition, and in November of 2015 was acquired in turn by Meditox, which soon renamed itself to Rennova Health. We don’t blame you for being confused by all the name changes, we’re confused ourselves.